Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open-Label Phase 2a Study-Reference-Cited by-同舟云学术

Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open-Label Phase 2a Study

Published:2016-01-18 Issue:2 Volume:33 Page:150-159
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:Pediatr Dermatol

Author:

Tom Wynnis L.¹,Van Syoc Merrie²,Chanda Sanjay²,Zane Lee T.²

Affiliation:

1. University of California, San Diego and Rady Children's Hospital; San Diego California

2. Anacor Pharmaceuticals; Palo Alto California

Funder

Anacor Pharmaceuticals, Inc., Palo Alto, CA

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pde.12780/fullpdf

Reference24 articles.

1. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies;Eichenfield;J Am Acad Dermatol,2014

2. Atopic dermatitis;Bieber;N Engl J Med,2008

3. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report;Akdis;J Allergy Clin Immunol,2006

4. The care triangle: determining the gaps in the management of atopic dermatitis;O'Toole;J Cutan Med Surg,2013

5. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis;Ellison;Pediatrics,2000

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical pharmacokinetic investigation of the bioavailability and skin distribution of HY-072808 ointment, a novel drug candidate for the treatment of atopic dermatitis, in minipigs by a newly LC-MS/MS method;Xenobiotica;2024-03-15

2. The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology;Chemical Reviews;2024-02-21

3. Kappa opioid agonists in the treatment of itch: just scratching the surface?;Itch;2023-10

4. Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review;British Journal of Clinical Pharmacology;2023-05-09

5. A validated UHPLC-MS/MS assay for rapid and sensitive determination of crisaborale in human plasma and its clinico-pharmacokinetic application;Journal of Pharmaceutical and Biomedical Analysis;2023-01